PHARMACEUTICAL INDUSTRY SYMPOSIUM 6 BY NOVARTIS
"Advances in Myelofibrosis and Polycythemia vera: Jakavi as the Current and Evolving Treatment"
Moderator : Prof. Irina Panovska-Stavridis
Ruxolitinib treatment for Myelofibrosis and Polycythemia vera; from long term follow up of Clinical trials to real-world evidence : Prof. Massimo Breccia, Sapienza University of Rome AOU Policlinico Umberto I – Rome
General sponsor:
Gold sponsors:
Other sponsors:
